Aquestive Therapeutics (AQST) Asset Utilization Ratio: 2018-2025
Historic Asset Utilization Ratio for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to -0.10.
- Aquestive Therapeutics' Asset Utilization Ratio fell 119.76% to -0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.10, marking a year-over-year decrease of 119.76%. This contributed to the annual value of 0.01 for FY2024, which is 98.56% down from last year.
- Aquestive Therapeutics' Asset Utilization Ratio amounted to -0.10 in Q3 2025, which was up 19.33% from -0.13 recorded in Q2 2025.
- Aquestive Therapeutics' 5-year Asset Utilization Ratio high stood at 0.87 for Q4 2023, and its period low was -0.13 during Q2 2025.
- In the last 3 years, Aquestive Therapeutics' Asset Utilization Ratio had a median value of 0.52 in 2024 and averaged 0.41.
- As far as peak fluctuations go, Aquestive Therapeutics' Asset Utilization Ratio spiked by 131.58% in 2022, and later plummeted by 126.84% in 2025.
- Aquestive Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.54 in 2021, then surged by 44.24% to 0.78 in 2022, then increased by 11.14% to 0.87 in 2023, then plummeted by 98.90% to 0.01 in 2024, then slumped by 119.76% to -0.10 in 2025.
- Its Asset Utilization Ratio stands at -0.10 for Q3 2025, versus -0.13 for Q2 2025 and -0.02 for Q1 2025.